Nevada Administrative Code
Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS
INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES
Miscellaneous Communicable Diseases
Section 441A.693 - Staphylococcus aureus : Vancomycin-resistant and vancomycin-intermediate
Universal Citation: NV Admin Code 441A.693
Current through September 16, 2024
1. The health authority shall investigate each report of a case having vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus to:
(a)
Confirm the diagnosis;
(b)
Identify, categorize and evaluate contacts; and
(c) Evaluate the efficacy of any contact
precautions, disease specific precautions or other infection control
precautions that are in effect.
2. If the case having vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus is in a medical facility, the medical facility must:
(a)
Provide care to the case in accordance with appropriate disease specific
precautions, including, without limitation:
(1) Isolating the case in a private
room;
(2) Minimizing the number of
persons providing care to the case; and
(3) Requiring any person who provides care to
the case to use contact precautions, including, without limitation:
(I) Wearing a sanitary mask and eye
protection if performing a procedure that is likely to cause the provider of
care to come into contact with contaminated material; and
(II) Using a cleansing agent for hand washing
that is appropriate for the disease;
(b) Dedicate for use only on the case any
nondisposable item that cannot be cleaned and disinfected between
uses;
(c) Inform and educate the
appropriate persons about:
(1) The presence in
the medical facility of a case with vancomycin-resistant or
vancomycin-intermediate Staphylococcus aureus; and
(2) The need to observe contact precautions,
disease specific precautions and other infection control precautions;
(d) Determine whether transmission
of vancomycin-resistant or vancomycin-intermediate Staphylococcus
aureus has already occurred by performing baseline cultures of
specimens from the hands and nares of:
(1) Any
person who has had physical contact with the case;
(2) Each health care provider of the case;
and
(3) Any roommate of the
case;
(e) Assess the
efficacy of any contact precautions, disease specific precautions or other
infection control precautions that are in effect by testing the appropriate
personnel for the acquisition of an isolate of vancomycin-resistant or
vancomycin-intermediate Staphylococcus aureus; and
(f) Consult with the health authority before
transferring or discharging the case from the medical facility.
Added to NAC by Bd. of Health by R087-08, eff. 1-13-2011
NRS 441A.120
Disclaimer: These regulations may not be the most recent version. Nevada may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
